BTcP Pharma v. Teva Pharmaceuticals USA, Inc. > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Nov 15, 2022 | 110 | REDACTED VERSION of 107 Stipulation of Dismissal by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) (Entered: 11/15/2022) (5) |
Nov 9, 2022 | 108 | [SEALED] SO ORDERED, re (107 in 1:17-cv-01303-CFC) Stipulation of Dismissal, filed by Teva Pharmaceuticals USA, Inc. CASE CLOSED. Signed by Judge Colm F. Connolly on 11/9/2022.This order has been emailed to local counsel. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC, 1:18-cv-01775-CFC(kmd) (Main Document 108 replaced on 11/9/2022) (kmd). (Entered: 11/09/2022) (0) |
Nov 9, 2022 | 109 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,486,972 B2; 8,486,973 B2; 8,835,459 B2; 8,835,460 B2; 9,241,935 B2. Sealed Stipulation of Dismissal signed by Chief Judge Connolly on 11/9/2022. (kmd) (Entered: 11/09/2022) (2) |
Nov 8, 2022 | 107 | [SEALED] STIPULATION of Dismissal by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) (Entered: 11/08/2022) (0) |
Oct 18, 2022 | 106 | REDACTED VERSION of 105 Letter by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) (Entered: 10/18/2022) (2) |
Oct 11, 2022 | 105 | [SEALED] Letter to The Honorable Colm F. Connolly from Nathan R. Hoeschen regarding request for an extension of time to submit a status report - re Oral Order, Status Report Order. (Hoeschen, Nathan) (Entered: 10/11/2022) (0) |
Apr 5, 2022 | 104 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Christopher P. Galligan as co-counsel. Reason for request: no longer with firm. (Ying, Jennifer) |
Mar 31, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. ยง 652(b). (Taylor, Daniel) |
Oct 2, 2019 | 103 | SO ORDERED (3) Docket Text: SO ORDERED, re [102] Stipulation and Order to Substitute Parties and Change Case Caption filed by Insys Development Company, Inc., Insys Therapeutics, Inc. BTcP Pharma added. Insys Therapeutics, Inc. and Insys Development Company, Inc. terminated. Signed by Judge Colm F. Connolly on 10/2/2019. (fms) |
Sep 30, 2019 | 102 | Stipulation (3) Docket Text: Joint STIPULATION and [Proposed] Order to Substitute Parties and Change Case Caption by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Ying, Jennifer) |
Aug 26, 2019 | 101 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Maja E. Sherman as co-counsel. Reason for request: no longer with Rakoczy Molino Mazzochi Siwik LLP. (Ying, Jennifer) |
Jul 19, 2019 | 100 | Stipulation (6) Docket Text: REDACTED VERSION of D.I. [98] - Joint STIPULATION and Proposed Order re [98] Stipulation (REDACTED) by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Ying, Jennifer) Modified on 7/22/2019 (fms). |
Jul 16, 2019 | N/A | Remark (0) Docket Text: The 7/24/2019 Discovery Conference is cancelled. (nmf) |
Jul 1, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [97] Joint STIPULATION TO EXTEND TIME for Rebuttal Expert Reports (Defendant rebuts objective indicia) to July 15, 2019 filed by Insys Development Company, Inc., Insys Therapeutics, Inc. Setting Scheduling Order Deadlines ( Rebuttal Expert Reports due by 7/15/2019.). Signed by Judge Colm F. Connolly on 7/1/2019. (fms) |
Jul 1, 2019 | 97 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME for Rebuttal Expert Reports (Defendant rebuts objective indicia) to July 15, 2019 - filed by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Ying, Jennifer) |
Jun 17, 2019 | 96 | Main Document (2) Docket Text: REDACTED VERSION of [95] Letter by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Attachments: # (1) Exhibit 1 & 2)(Ying, Jennifer) |
Jun 17, 2019 | 96 | Exhibit 1 & 2 (47) |
Jun 14, 2019 | N/A | Set Deadlines/Hearings (0) Docket Text: Set Hearings: The Discovery Conference set for 6/20/2019 at 03:00 PM is rescheduled per request of counsel for 7/24/2019 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. (fms) |
Jun 3, 2019 | 94 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Opening Expert Report of Hugh Smyth, Ph.D. Regarding Invalidity filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
May 31, 2019 | 93 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Opening Expert Report of Edward M. Rudnic, Ph.D., 2) Opening Expert Report of Richard Rauck, M.D., and 3) Opening Expert Report of David E. Bugay, Ph.D. filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
May 24, 2019 | 92 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Infringement Contentions Against Teva for the 460, 844, 973 and 459 Patents filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
May 16, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [91] Joint STIPULATION TO EXTEND TIME to extend Opening Expert Reports deadline to May 31, 2019 filed by Insys Therapeutics, Inc., Set/Reset Scheduling Order Deadlines: ( Opening Expert Reports due by 5/31/2019.). Signed by Judge Colm F. Connolly on 5/16/2019. (fms) |
May 16, 2019 | 91 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME to extend Opening Expert Reports deadline to May 31, 2019 - filed by Insys Therapeutics, Inc.. (Ying, Jennifer) |
May 8, 2019 | N/A | Set/Reset Hearings (0) Docket Text: Set Hearings: A Discovery Conference is set per request of counsel for 6/20/2019 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. (nmf) |
May 2, 2019 | 90 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of S. George Kottayil on May 7, 2019 filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
May 1, 2019 | 89 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Supplemental Objections and Responses to Defendant's First Set of Interrogatories (No. 8) filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
Apr 26, 2019 | 88 | Notice (Other) (6) Docket Text: NOTICE of Subpoena of S. George Kottayil by Insys Development Company, Inc., Insys Therapeutics, Inc. (Ying, Jennifer) |
Apr 24, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [87] MOTION for Pro Hac Vice Appearance of Attorney Lauren A. Watt filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Colm F. Connolly on 4/24/2019. (fms) |
Apr 23, 2019 | 86 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's Notice of Deposition of Lisa Thelen Pursuant to Federal Rule of Civil Procedure 30(b)(1) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
Apr 23, 2019 | 87 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Lauren A. Watt - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
Apr 18, 2019 | 82 | Redacted Document (30) Docket Text: REDACTED VERSION of [71] Letter, by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
Apr 18, 2019 | 83 | Redacted Document (24) Docket Text: REDACTED VERSION of [73] Letter by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
Apr 18, 2019 | 84 | Main Document (4) Docket Text: REDACTED VERSION of [72] Letter by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Attachments: # (1) Exhibit A-B, # (2) Exhibit 1-4)(Ying, Jennifer) |
Apr 18, 2019 | 84 | Exhibit A-B (4) |
Apr 18, 2019 | 84 | Exhibit 1-4 (16) |
Apr 18, 2019 | 85 | Main Document (4) Docket Text: REDACTED VERSION of [74] Letter by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Attachments: # (1) Exhibit 1-4)(Ying, Jennifer) |
Apr 18, 2019 | 85 | Exhibit 1-4 (22) |
Apr 17, 2019 | 81 | Order (1) Docket Text: ORDER re [71] Letter from Teva Pharmaceuticals USA, Inc. Signed by Judge Colm F. Connolly on 4/16/2019. (nmf) |
Apr 16, 2019 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Discovery Conference held on 4/16/2019. (Court Reporter V. Gunning.) (nmf) |
Apr 15, 2019 | 78 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Cherri Petrie on April 19, 2019 filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
Apr 15, 2019 | 79 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Harshil Parikh on April 18, 2019 filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
Apr 15, 2019 | 80 | SO ORDERED (2) Docket Text: SO ORDERED, re [76] Joint STIPULATION TO EXTEND TIME deadlines in the Scheduling Order to various dates filed by Insys Development Company, Inc., Insys Therapeutics, Inc. ( Opening Expert Reports due by 5/21/2019., Rebuttal Expert Reports due by 7/8/2019.). Signed by Judge Colm F. Connolly on 4/15/2019. (fms) |
Apr 12, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Maja E. Sherman,Katie A. Boda,Paul J. Molino for Insys Development Company, Inc., Insys Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
Apr 12, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Paul J. Molino,Katie A. Boda,Maja E. Sherman for Insys Development Company, Inc., Insys Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
Apr 12, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Tara Mythri Raghavan for Insys Development Company, Inc. and Insys Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (amf) |
Apr 12, 2019 | 75 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s Supplemental Invalidity Contentions filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
Apr 12, 2019 | 76 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME deadlines in the Scheduling Order to various dates - filed by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Ying, Jennifer) |
Apr 12, 2019 | 77 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendant's Third Set of Interrogatories (No. 10); and (2) Plaintiffs' Amended Supplemental Objections and Responses to Defendant's First Set of Interrogatories (Nos. 2 and 4-7) filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
Apr 11, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [70] MOTION for Pro Hac Vice Appearance of Attorney Paul J. Molino, Katie A. Boda and Maja E. Sherman filed by Insys Development Company, Inc., Insys Therapeutics, Inc. Signed by Judge Colm F. Connolly on 4/11/2019. (fms) |
Apr 11, 2019 | 70 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Paul J. Molino, Katie A. Boda and Maja E. Sherman - filed by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Ying, Jennifer) |
Apr 10, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER Rescheduling Hearings, Due to a conflict in the Court's schedule, the Discovery Conference is rescheduled for 4/16/2019 at 01:00 PM in Courtroom 4B before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 4/10/2019. (nmf) |
Apr 8, 2019 | 69 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's Objections and Responses to Plaintiffs' Notice of Deposition of Teva Pharmaceuticals USA, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
Mar 20, 2019 | 68 | Notice to Take Deposition (8) Docket Text: NOTICE to Take Deposition of Defendant Teva Pharmaceuticals USA, Inc. on the time, place and date agreed upon in writing by counsel for the parties filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
Mar 19, 2019 | 65 | Notice (Other) (30) Docket Text: NOTICE of Subpoenas Directed to Linet Kattookaran, S. George Kottayil, Elena Renaud, Stephen Sherman, and Zhongyuan Zhu, Ph.D. by Teva Pharmaceuticals USA, Inc. (Hoeschen, Nathan) |
Mar 19, 2019 | 66 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant's Notice of Deposition of Insys Therapeutics, Inc. and Insys Development Company, Inc. Pursuant to Fed. R. Civ. P. 30(B)(6) filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
Mar 19, 2019 | 67 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Plaintiffs' Amended Supplemental Objections and Responses to Defendant's First Set of Interrogatories (No. 8) and 2) Plaintiffs' Amended Supplemental Objections and Responses to Defendant's Second Set of Interrogatories (No. 9) filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
Mar 15, 2019 | N/A | Set/Reset Hearings (0) Docket Text: Set/Reset Hearings: A Discovery Conference is set per request of counsel for 4/16/2019 at 11:00 AM in Courtroom 4B before Judge Colm F. Connolly. (nmf) |
Mar 15, 2019 | 64 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s Initial Invalidity Contentions Regarding U.S. Patent No. 10,016,403 filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
Mar 13, 2019 | 63 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Tevas Third Set of Interrogatories to Insys Therapeutics, Inc. and Insys Development Company, Inc. (No. 10) filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
Feb 28, 2019 | 62 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's Supplemental Response to Plaintiffs' First Set of Interrogatories (No. 7) filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
Feb 27, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [59] MOTION for Pro Hac Vice Appearance of Attorney Tara Mythri Raghavan of Rakoczy Molino Mazzochi Sewik, LLP filed by Insys Development Company, Inc., Insys Therapeutics, Inc. Signed by Judge Colm F. Connolly on 2/27/2019. (fms) |
Feb 27, 2019 | 59 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Tara Mythri Raghavan of Rakoczy Molino Mazzochi Sewik, LLP - filed by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Ying, Jennifer) |
Feb 27, 2019 | 60 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Privilege Log filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
Feb 27, 2019 | 61 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Objections and Responses to Defendants Second Set of Interrogatories (No. 9) filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
Feb 26, 2019 | 58 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's Notice of Deposition of Insys Therapeutics, Inc. and Insys Development Company, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
Feb 21, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Joseph T. Jaros,William A. Rakoczy,Christopher P. Galligan for Insys Development Company, Inc., Insys Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
Feb 19, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Oral Order (DI 58 in 17-1303; DI 24 in 18-414; DI 16 in 18-1308; and DI 12 in 18-1775) resetting the time for the teleconference on 2/26/19 to 11:00 am was docketed in error and was removed from the docket. The teleconference was rescheduled to 4/23/19 at 10:00 a.m. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC, 1:18-cv-01775-CFC(cak) |
Feb 12, 2019 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 2/12/2019. (Court Reporter V. Gunning.) (nmf) |
Feb 11, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [57] MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Joseph T. Jaros and Chris P. Galligan of RAKOCZY MOLINO MAZZOCHI SIWIK LLP filed by Insys Development Company, Inc., Insys Therapeutics, Inc. Signed by Judge Colm F. Connolly on 2/11/2019. (fms) |
Feb 11, 2019 | N/A | Set/Reset Hearings (0) Docket Text: Set/Reset Hearings: The Markman Hearing is rescheduled for 2/12/2019 at 10:00 AM in Courtroom 4B before Judge Colm F. Connolly. (nmf) |
Feb 7, 2019 | 56 | Notice (Other) (1) Docket Text: NOTICE of Substitution of Counsel by Insys Development Company, Inc., Insys Therapeutics, Inc. (Ying, Jennifer) |
Feb 7, 2019 | 57 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Joseph T. Jaros and Chris P. Galligan of RAKOCZY MOLINO MAZZOCHI SIWIK LLP - filed by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Ying, Jennifer) |
Feb 4, 2019 | 55 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendant's Notice of Deposition of Venkat R. Goskonda; 2) Defendant's Notice of Deposition of Linet Kattookaran; 3) Defendant's Notice of Deposition of S. George Kottayil; 4) Defendant's Notice of Deposition of Neha Parikh; 5) Defendant's Notice of Deposition of Elena Renaud; 6) Defendant's Notice of Deposition of Stephen Sherman; and 7) Defendant's Notice of Deposition of Zhongyuan Zhu filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
Jan 25, 2019 | 54 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions Against Teva for the '403 Patent filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
Jan 22, 2019 | 53 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Objections and Responses to Defendant's First Set of Interrogatories (Nos. 2-8) filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
Jan 14, 2019 | 52 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant's Second Set of Interrogatories (No. 9) filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
Jan 11, 2019 | 51 | Main Document (73) Docket Text: Joint CLAIM CONSTRUCTION OPENING BRIEF filed by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Attachments: # (1) Appendix Joint Appendix)(Ying, Jennifer) |
Jan 11, 2019 | 51 | Appendix Joint Appendix (347) |
Jan 7, 2019 | 50 | SO ORDERED (6) Docket Text: SO ORDERED, re (10 in 1:18-cv-01775-CFC, 49 in 1:17-cv-01303-CFC) Stipulation and Proposed Order to Consolidate and Dismiss Teva Pharmaceutical Industries, Ltd. filed by Insys Development Company, Inc., Insys Therapeutics, Inc. Party Teva Pharmaceutical Industries Ltd. terminated from 18-1775 CFC. The parties agree to consolidate the 1775 action into the consolidated 1303 action for all purposes and that ALL PAPERS WILL BE FILED IN C.A. No. 17-1303. See Stipulation for further details. Signed by Judge Colm F. Connolly on 1/7/2019. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-01775-CFC(fms) |
Jan 4, 2019 | 49 | Proposed Order (6) Docket Text: Joint PROPOSED ORDER Stipulation and [Proposed] Order to Consolidate and Dismiss Teva Pharmaceutical Industries, Ltd. by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Ying, Jennifer) |
Dec 21, 2018 | 48 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
Dec 14, 2018 | 47 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Teva's Second Set of Interrogatories to Insys Therapeutics, Inc. and Insys Development Company, Inc. (No. 9) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
Nov 6, 2018 | 46 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
Oct 29, 2018 | 45 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendant Teva's Responses and Objections to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-86); and 2) Defendant's Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-9) filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
Oct 18, 2018 | 44 | Scheduling Order (8) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 9/27/2018. Amended Pleadings due by 2/15/2019. Discovery due by 4/12/2019. Claim Construction Opening Brief due by 11/6/2018. Claim Construction Answering Brief due by 12/3/2018. Claim Construction Reply Brief due by 12/21/2018. Claim Construction Surreply Brief due by 1/8/2019. Joint Claim Construction Brief due to the Court by 1/11/2019. A Markman Hearing is set for 2/12/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 9/9/2019. A Final Pretrial Conference is set for 9/23/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 10/15/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 10/18/2018. (nmf) |
Oct 15, 2018 | 42 | Main Document (8) Docket Text: Joint PROPOSED ORDER -- [Proposed] Scheduling Order -- by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Ying, Jennifer) |
Oct 15, 2018 | 42 | Letter to The Honorable Colm F. Connolly (1) |
Oct 15, 2018 | 43 | Main Document (7) Docket Text: CLAIM Construction Chart by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Attachments: # (1) Exhibits A-S)(Ying, Jennifer) |
Oct 15, 2018 | 43 | Exhibits A-S (762) |
Oct 4, 2018 | 41 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva's List of Claim Terms for Construction filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
Oct 2, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Josephine J. Kim for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, ) |
Oct 1, 2018 | 40 | Order (1) Docket Text: ORDER, IT IS ORDERED that the parties shall incorporate the deadlines and discovery limitations currently in effect (as revised by the Court's order of September 27, 2018) into a proposed revised scheduling order that is based on the Court's "Rule 16 Scheduling Order for Patent Cases" available on the Court's website. Signed by Judge Colm F. Connolly on 10/1/2018. (nmf) |
Sep 28, 2018 | 39 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Plaintiffs' First Set of Interrogatories and 2) Plaintiffs' First Set of Requests for Production of Documents and Things filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
Sep 27, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The text in DI 37 was changed to indicate it is an ORAL ORDER. (cak) |
Sep 27, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [38] MOTION for Pro Hac Vice Appearance of Attorney Josephine J. Kim filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Colm F. Connolly on 9/27/2018. (fms) |
Sep 27, 2018 | 36 | Scheduling Order (6) Docket Text: CONSOLIDATION AND SCHEDULING ORDER: Teva Pharmaceutical Industries, Ltd. is dismissed. THESE CASES ARE CONSOLIDATED FOR ALL PURPOSES AND ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 17-1303-CFC. Joinder of Parties due by 9/27/2018. Claim Construction Opening Brief Served by 11/6/2018. Claim Construction Answering Brief Served by 12/3/2018. Claim Construction Reply Brief Served by 12/21/2018. Claim Construction Surreply Brief Served by 1/8/2019. Parties to File Joint Claim Construction Brief & Joint Appendix of Evidence by 1/11/2019. A Markman Hearing is set for 2/12/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 9/9/2019. A Final Pretrial Conference is set for 9/23/2019 at 10:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 10/15/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 9/26/2018. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC(nmf) |
Sep 27, 2018 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. The teleconference with Judge Thynge set for 2/26/2019 at 10:00 AM Eastern Time to discuss the status of the matters and ADR has been rescheduled to 4/23/2018 at 10:00 AM Eastern Time. Ordered by Judge Mary Pat Thynge on 9/27/18. (cak) Modified on 9/27/2018 (cak). |
Sep 27, 2018 | 38 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Josephine J. Kim - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
Sep 24, 2018 | 35 | Stipulation (6) Docket Text: Joint STIPULATION and [Proposed] Order to Consolidate Actions and Dismiss Teva Pharmaceutical Industries Ltd. by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Ying, Jennifer) |
Sep 18, 2018 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephonic Scheduling Conference held on 9/18/2018. (Court Reporter V. Gunning.) Counsel to submit a revised stipulation regarding scheduling and consolidation to the Court. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC(nmf) |
Sep 17, 2018 | 34 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Teva Pharmaceuticals USA, Inc.'s Initial Invalidity Contentions filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd..(Shaw, John) |
Sep 14, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Chad J. Peterman for Insys Development Company, Inc. and Insys Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
Sep 13, 2018 | 33 | Order Setting Scheduling Conference (2) Docket Text: Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 9/18/2018 at 02:00 PM before Judge Colm F. Connolly to discuss the parties' proposed modifications to the case schedule as outlined in the stipulation of September 11, 2018. Counsel for plaintiffs shall coordinate and initiate the call to chambers. Signed by Judge Colm F. Connolly on 9/13/2018. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC(nmf) |
Sep 12, 2018 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: Plaintiff's counsel to initiate the call. A Telephone Conference is set for 2/26/2019 at 10:00 AM Eastern Time before Judge Mary Pat Thynge to discuss the status of the matters and ADR. Ordered by Judge Mary Pat Thynge on 9/12/18. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC(cak) |
Sep 11, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC (rjb) |
Sep 11, 2018 | 31 | Stipulation (5) Docket Text: STIPULATION [And [Proposed] Order To Consolidate Actions And Dismiss Teva Pharmaceutical Industries, Ltd by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) Modified on 9/11/2018 (mdb). |
Aug 22, 2018 | 30 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions Against Teva for the '972, '973, '459, '460, '935, '387, '797, and '844 Patents filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Blumenfeld, Jack) |
Jul 18, 2018 | 28 | Notice Requesting Removal of Co-Counsel (3) Docket Text: NOTICE requesting Clerk to remove Gerald J. Flattmann, Jr. as co-counsel. Reason for request: no longer associated with Paul Hastings. (Noreika, Maryellen) |
Jul 18, 2018 | 29 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Amended Rule 26(a)(1) Initial Disclosures and (2) Plaintiffs' First Amended Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Noreika, Maryellen) |
Jul 16, 2018 | 27 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants First Set of Interrogatories (Nos. 1-8) and (2) Plaintiffs' Objections and Responses to Defendants First Set of Requests for Production (Nos. 1-75) filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Noreika, Maryellen) |
May 24, 2018 | 26 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Teva's First Set of Interrogatories to Insys Therapeutics, Inc. and Insys Development Company, Inc. (Nos. 1-8) (2) Teva's First Set of Requests for Production to Plaintiffs Insys Therapeutics, Inc. and Insys Development Company, Inc. (Nos. 1-75) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
Apr 9, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [22] Stipulation of Dismissal Of Complaint As To Defendant Teva Pharmaceutical Industries Ltd. And Amendment Of Caption. Party Teva Pharmaceutical Industries Ltd. terminated. Ordered by Judge Gregory M. Sleet on 4/9/2018. (mdb) |
Apr 9, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [23] Proposed Stipulated Protective Order. Ordered by Judge Gregory M. Sleet on 4/9/2018. (mdb) |
Apr 9, 2018 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
Apr 9, 2018 | 25 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Noreika, Maryellen) |
Apr 5, 2018 | 23 | Proposed Order (20) Docket Text: PROPOSED ORDER -- Stipulated Protective Order -- by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Noreika, Maryellen) |
Mar 28, 2018 | 22 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal Of Complaint As To Defendant Teva Pharmaceutical Industries Ltd. And Amendment Of Caption by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Shaw, John) Modified on 3/28/2018 (mdb). |
Mar 23, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [19] STIPULATION TO EXTEND TIME for the parties to submit a proposed Protective Order; for defendants to produce Paragraph 4(b) disclosures; and for defendants to produce samples to April 5, 2018 and two and three weeks after the proposed Protective Order filed by Insys Development Company, Inc., Insys Therapeutics, Inc.. Ordered by Judge Gregory M. Sleet on 3/23/2018. (mdb) |
Mar 23, 2018 | 21 | Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 4/16/2018 at 10:30 AM Eastern Time before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 3/23/18. (cak) |
Mar 22, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [17] Proposed Scheduling Order. Case is referred to the Magistrate Judge for the purpose of exploring ADR. (Motions for Joinder of Parties due by 7/9/2018., Motions to Amend Pleadings due by 2/15/2019., Claim Construction Opening Briefs due by 10/12/2018., Claim Construction Answering Briefs due by 11/9/2018., A Markman Hearing (full day) is set for 1/3/2019 at 9:30 AM in Courtroom 4A., Fact Discovery completed by 2/15/2019., Opening Expert Reports due by 8/12/2019., Rebuttal Expert Reports due by 7/14/2019., Expert Discovery due by 7/25/2019., Proposed Final Pretrial Order due by the close of business on 9/9/2019., A Final Pretrial Conference is set for 9/23/2019 at 10:00 AM via telephone., and a 5-day Bench Trial is set for 10/14/2019 at 09:00 AM in Courtroom 4A. See Scheduling Order ([17]) for full schedule). Ordered by Judge Gregory M. Sleet on 3/22/2018. (mdb) |
Mar 22, 2018 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak) |
Mar 22, 2018 | 18 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Rule 26 Initial Disclosures filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
Mar 22, 2018 | 19 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed Protective Order; for defendants to produce Paragraph 4(b) disclosures; and for defendants to produce samples to April 5, 2018 and two and three weeks after the proposed Protective Order is filed, respectively - filed by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Noreika, Maryellen) |
Mar 22, 2018 | 20 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Noreika, Maryellen) |
Mar 15, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [16] STIPULATION TO EXTEND TIME for the parties to file a proposed Protective Order to March 22, 2018 filed by Insys Development Company, Inc., Insys Therapeutics, Inc.. Ordered by Judge Gregory M. Sleet on 3/15/2018. (mdb) |
Mar 15, 2018 | 16 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for the parties to file a proposed Protective Order to March 22, 2018 - filed by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Noreika, Maryellen) |
Mar 15, 2018 | 17 | Main Document (7) Docket Text: Joint PROPOSED ORDER Revised Scheduling Order by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Attachments: # (1) Cover Letter)(Noreika, Maryellen) |
Mar 15, 2018 | 17 | Cover Letter (1) |
Mar 8, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [15] Joint Status Report - The parties' proposed schedule is ADOPTED, with the following additions: The Markman Hearing (full day) is set for 1/3/2019 at 9:30 AM in Courtroom 4A, the Proposed Final Pretrial Order is due by the close of business on 9/9/2019, the Final Pretrial Conference is set for 9/23/2019 at 10:00 AM via telephone, and a 5-day Bench Trial is set for 10/14/2019 at 9:00 AM in Courtroom 4A. This case is referred to the Magistrate Judge for exploring ADR. The plaintiff shall file an amended proposed scheduling order incorporating the full schedule within seven (7) days of this order. Ordered by Judge Gregory M. Sleet on 3/8/2018. (mdb) |
Mar 2, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Naveen Modi,Michael A. Stramiello,Gerald J. Flattmann, Jr for Insys Development Company, Inc.,Naveen Modi,Michael A. Stramiello,Gerald J. Flattmann, Jr for Insys Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, ) |
Feb 15, 2018 | 15 | Main Document (7) Docket Text: Joint STATUS REPORT by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Noreika, Maryellen) |
Feb 15, 2018 | 15 | Exhibit A (2) |
Feb 15, 2018 | 15 | Exhibit B (5) |
Feb 5, 2018 | 14 | Answer to Counterclaim (9) Docket Text: ANSWER to [10] Answer to Complaint, Counterclaim by Insys Development Company, Inc., Insys Therapeutics, Inc..(Blumenfeld, Jack) |
Jan 17, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Paul A. Ainsworth,John C. Rozendaal,Deirdre M. Wells for Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
Jan 16, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [9] MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal, Paul A. Ainsworth and Deirdre Wells filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. Ordered by Judge Gregory M. Sleet on 1/16/2018. (mdb) |
Jan 16, 2018 | 13 | Order (2) Docket Text: ORDER REGARDING CASE MANAGEMENT CIVIL CASES. Signed by Judge Gregory M. Sleet on 1/16/2017. (asw) |
Jan 15, 2018 | 10 | Answer to Complaint (18) Docket Text: ANSWER to [1] Complaint, and, COUNTERCLAIM against Insys Development Company, Inc., Insys Therapeutics, Inc. by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc..(Keller, Karen) Modified on 1/16/2018 (mdb). |
Jan 15, 2018 | 11 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceuticals Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
Jan 15, 2018 | 12 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Teva Pharmaceutical Industries Ltd.. (Keller, Karen) |
Jan 11, 2018 | 9 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal, Paul A. Ainsworth and Deirdre Wells - filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
Sep 22, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [8] MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Chad J. Peterman, Naveen Modi, Michael A. Stramiello, and Lucas L. Kressel filed by Insys Development Company, Inc., Insys Therapeutics, Inc. Ordered by Judge Gregory M. Sleet on 9/22/2017. (mdb) |
Sep 21, 2017 | 8 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Chad J. Peterman, Naveen Modi, Michael A. Stramiello, and Lucas L. Kressel - filed by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Noreika, Maryellen) |
Sep 20, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb) |
Sep 19, 2017 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Insys Therapeutics, Inc., Insys Development Company, Inc.. Teva Pharmaceuticals USA, Inc. served on 9/18/2017, answer due 10/10/2017. (Blumenfeld, Jack) |
Sep 19, 2017 | 7 | Stipulation (2) Docket Text: STIPULATION and Proposed Order Regarding Waiver of Service and to Extend Time by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Noreika, Maryellen) |
Sep 14, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceutical Industries Ltd. on 9/14/2017; Teva Pharmaceuticals USA, Inc. on 9/14/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmfn) |
Sep 13, 2017 | 1 | Main Document (10) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2223298.) - filed by Insys Therapeutics, Inc., Insys Development Company, Inc. (Attachments: # (1) Exhibits A-H, # (2) Civil Cover Sheet)(nmfn) |
Sep 13, 2017 | 1 | Exhibits A-H (351) |
Sep 13, 2017 | 1 | Civil Cover Sheet (1) |
Sep 13, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn) |
Sep 13, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/1/2017. Date of Expiration of Patent: 1/25/2027; 4/27/2030. Thirty Month Stay Deadline: 2/1/2020. (nmfn) |
Sep 13, 2017 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,486,972 B2; 8,486,973 B2; 8,835,459 B2; 8,835,460 B2; 9,241,935 B2; 9,289,387 B2; 9,642,797 B2; 9,642,844 B2. (nmfn) |
Sep 13, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Insys Therapeutics, Inc. for Insys Development Company, Inc. filed by Insys Development Company, Inc., Insys Therapeutics, Inc. (nmfn) |
Sep 13, 2017 | 1 | Complaint* (1) |